secwatch.observer — SEC 8-K summary
======================================

Issuer:     HERON THERAPEUTICS, INC. /DE/ (HRTX)
CIK:        0000818033
Form:       8-K
Filed at:   2024-12-23T23:59:59+00:00
Accession:  0000950170-24-139569
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Heron Therapeutics moves HQ from San Diego to Cary, NC effective Jan 1, 2025
----------------------------------------------------------------------------

- New corporate headquarters at 100 Regency Forest Dr, Suite 300, Cary, NC 27518.
- Majority of management team and corporate employees already based in Cary near Research Triangle Park.
- CEO Craig Collard says move centralizes operations and supports strategic partnerships.
- Company will continue focusing on acute and oncology care therapies from new location.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/818033/000095017024139569/0000950170-24-139569-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/818033/000095017024139569/hrtx-20241223.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-139569

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer